Related Experiment Video
Updated: Jun 25, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.6K
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma
G K Scadding1,2, C Gray3,4, D M Conti5,6
1Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom.
Frontiers in Allergy
|May 30, 2024
Summary
Preventing asthma is crucial. This study explores interventions for individuals at high risk, similar to pre-diabetes management, focusing on late-onset eosinophilic asthma prevention.
Area of Science:
- Allergy and immunology
- Respiratory medicine
- Preventive medicine
Background:
- The concept of pre-diabetes informs strategies for diabetes prevention.
- Pre-asthma, analogous to pre-diabetes, identifies individuals at risk for developing asthma.
- Allergen immunotherapy (AIT) shows promise in preventing asthma in children with allergic rhinitis.
Purpose of the Study:
- To explore preventive strategies for late-onset eosinophilic asthma.
- To investigate potential interventions for individuals at high risk of developing asthma.
- To build upon previous research on pre-asthma and AIT for primary prevention.
Main Methods:
- Review of existing literature on pre-asthma and AIT.
- Exploration of potential interventions for late-onset eosinophilic asthma.
- Analysis of strategies to reduce asthma development in at-risk populations.
Main Results:
- Allergen immunotherapy (AIT) has evidence supporting asthma prevention in children with allergic rhinitis.
- Further research is needed to establish AIT as a primary prevention method for asthma.
- Specific interventions for late-onset eosinophilic asthma require further investigation.
Conclusions:
- Preventive measures, akin to pre-diabetes management, are essential for asthma control.
- Allergen immunotherapy (AIT) is a potential strategy for asthma prevention, particularly in allergic rhinitis.
- Targeted interventions are needed to prevent the development of late-onset eosinophilic asthma.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271

